New data reveals that percutaneous coronary intervention (PCI) can be safely performed before, during, or after transcatheter aortic valve replacement (TAVR) for patients with stable coronary artery ...
Nonrandomized studies have shown that patients who undergo percutaneous coronary intervention (PCI) can be safely discharged from hospital after a short observation period, but these trials were ...
Interventional cardiology made its debut 27 years ago, when Andreas Grüntzig performed the first percutaneous transluminal coronary angioplasty in a human. Since then, rapid expansion of our knowledge ...
A new expert opinion from the Society for Cardiovascular Angiography & Interventions (SCAI) examines the evolving role of angiography-derived physiology (ADP), a wire-free method for coronary ...
There are differential benefits associated with a percutaneous coronary intervention–capable facility (PCI-CF) opening based on patient race and community segregation, according to a research letter ...
Percutaneous coronary intervention procedures performed in an ASC may result in increased bleeding complications, according to a study published in JACC: Cardiovascular Interventions. Medpage Today ...
Age-related physiological changes augment both the potential benefit of coronary revascularization and the risk of procedure-related adverse outcomes A broad range of antithrombin and antiplatelet ...
Background: A shorter time from symptom onset to reperfusion is associated with improved outcomes for patients with ST-segment elevation myocardial infarction (MI). Primary percutaneous coronary ...
WALTHAM, Mass.--(BUSINESS WIRE)--Corindus, a Siemens Healthineers company and a leading developer of precision vascular robotics, announced today it has completed the first multi-city, ...
Drug-eluting coronary-artery stents have been shown to decrease restenosis and therefore the likelihood that additional procedures will be required after percutaneous coronary intervention (PCI). We ...
Certification to perform catheter-based interventions for coronary artery disease was originally limited to hospitals that had the capability to perform cardiac surgery on site. However, there has ...
A team of scientists from Iran has recently estimated the prevalence of coronavirus disease 2019 (COVID-19) in myocardial infarction patients receiving a primary percutaneous coronary intervention. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results